Skip to main content

MPM Asset Management LLC

SEC CIK
0001263048
Latest filing
Nov 14, 2025

TCRR holding history

TCR2 Therapeutics Inc. in every 13F filed by MPM Asset Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TCRR overviewAll 13F holders of TCRRFull Q3 2025 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
9
Since Q1 2021
Holdings of TCRR by MPM Asset Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−4,050,865−100.0%Sold outHolders
Q1 20234,050,865$6.08M2.5%00.0%UnchangedHolders
Q4 20224,050,865$4.05M1.7%00.0%UnchangedHolders
Q3 20224,050,865$7.29M2.8%00.0%UnchangedHolders
Q2 20224,050,865$11.7M5.0%00.0%UnchangedHolders
Q1 20224,050,865$11.2M3.8%00.0%UnchangedHolders
Q4 20214,050,865$18.9M4.1%00.0%UnchangedHolders
Q3 20214,050,865$34.5M8.0%00.0%UnchangedHolders
Q2 20214,050,865$66.5M12.4%00.0%UnchangedHolders
Q1 20214,050,865$89.4M17.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.